ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA expands approval of Adcetris for Stage III or IV classical Hodgkin lymphoma
March 27, 2018The FDA has approved Adcetris to treat adult patients with previously untreated stage III or IV classical Hodgkin lymphoma in combination with chemotherapy… -
FDA Approves Seattle Genetics' Adcetris to Treat Disfiguring Blood Cancer
November 10, 2017Seattle Genetics Announces FDA Approval of ADCETRIS (Brentuximab Vedotin) for Primary Cutaneous Anaplastic Large Cell Lymphoma (pcALCL) and CD30-Expressing Mycosis Fungoides (MF)
Pharma Sources Insight January 2025
